Boston Therapeutics, Inc.
BTHE · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $1,111 | $1,025 | $1,025 | $515 |
| - Cash | $7 | $7 | $12 | $137 |
| + Debt | $4,835 | $4,050 | $2,830 | $2,502 |
| Enterprise Value | $5,939 | $5,069 | $3,842 | $2,880 |
| Revenue | $9 | $16 | $32 | $29 |
| % Growth | -42.8% | -48.5% | 8.1% | – |
| Gross Profit | -$23 | -$11 | -$35 | $29 |
| % Margin | -243.2% | -65.4% | -111.6% | 100% |
| EBITDA | -$477 | -$1,879 | -$2,712 | $138 |
| % Margin | -5,112.8% | -11,507.2% | -8,549.5% | 471.7% |
| Net Income | -$908 | -$3,694 | -$3,601 | -$1,585 |
| % Margin | -9,724.5% | -22,622.8% | -11,352.1% | -5,398.8% |
| EPS Diluted | -0.008 | -0.036 | -0.035 | -0.031 |
| % Growth | 77.2% | -2.6% | -14% | – |
| Operating Cash Flow | -$784 | -$1,196 | -$884 | -$1,275 |
| Capital Expenditures | $0 | $0 | $0 | -$5 |
| Free Cash Flow | -$784 | -$1,196 | -$884 | -$1,280 |